NCT04384562View on ClinicalTrials.gov

Studying the Role of Brain Molecules for Decision Making

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

December 13, 2021

Study Completion Date

December 13, 2021

Conditions
Decision MakingHealthy
Interventions
DRUG

Methylphenidate

A 20 mg methylphenidate (Ritalin®) is administered only once for the dopamine reuptake inhibitor group.

DRUG

Reboxetine

A 4 mg reboxetine (Edronax®) is administered only once for the noradrenaline reuptake inhibitor group.

DRUG

Nicotine gum

A 2 mg nicotine (Nicorette®) gum is administered only once for the cholinergic receptor agonist group.

DRUG

Placebo pill

A placebo pill is administered only once.

DRUG

Placebo gum

A placebo gum is administered only once.

Trial Locations (1)

8006

University of Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT04384562 - Studying the Role of Brain Molecules for Decision Making | Biotech Hunter | Biotech Hunter